Introduction {#sec1_1}
============

Pancreatic pseudocyst formation is a well-known complication in chronic and acute pancreatitis that can cause local complications and pain. The prevalence of pseudocysts among patients with chronic pancreatitis approximates 20--40%; however, this may be overestimated due to changes in the nomenclature of peripancreatic fluid collections in the revised Atlanta classification \[[@B1], [@B2]\]. In patients with acute pancreatitis, the development of a pancreatic pseudocyst is extremely rare and usually occurs delayed after \> 4 weeks \[[@B2]\]. Pancreatic pseudocysts are defined as localized fluid collections in (peri-)pancreatic tissue which contain a fluid rich in pancreatic enzymes without any solid material and have a well-defined, nonepithelialized wall consisting of fibrous and granulated tissue. They are to be distinguished from acute peripancreatic fluid collections, acute necrotic collections, and walled-off necrosis. Diagnoses can usually be made based on morphologic criteria \[[@B2], [@B3]\].

Another complication in patients suffering from acute or chronic pancreatitis is the formation of (pseudo-)aneurysms of intestinal vessels, a rare but life-threatening complication if bleeding of the pseudoaneurysm occurs, with a mortality of 30--50% \[[@B4]-[@B10]\]. The formation of (pseudo-)aneurysms and arrosions of vessels are triggered by inflammation of the pancreas and the surrounding tissue, extravasation of proteolytic enzymes, formation of pseudocysts, extensive necrosis, or abscesses \[[@B11], [@B12]\].

Here we report the clinical case of a patient with an arterial pseudoaneurysm within a pancreatic pseudocyst and show the prophylactic therapy to prevent critical bleeding.

Case Report {#sec1_2}
===========

A 67-year-old male with a 3.5-year history of chronic alcoholic pancreatitis presented with severe acute abdominal pain and vomiting to the emergency department of a teaching hospital. The patient had experienced a first episode of acute alcoholic pancreatitis 7 years previously, and at least three subsequent acute attacks of chronic pancreatitis within the last 3.5 years. Seven weeks prior to the present admission, he had suffered from the last acute attack, and a CT scan revealed a pancreatic pseudocyst at the pancreatic tail with a maximum diameter of 53 mm. There was no indication for intervention at that time. The patient reported an alcohol intake of 1--2 L of beer per day and hard liquor intake once a month as well as regular cigarette smoking (45 pack-years). The patient was on oral anticoagulation due to atrial fibrillation and had been suffering from arterial hypertension and insulin-dependent diabetes mellitus for 3.25 years. He reported reduced enteral food intake due to abdominal pain, particularly postprandially, and a weight loss of 20 kg (24%) within the previous 12 months without night sweat.

On admission, a blood pressure of 190/89 mm Hg and a regular heartbeat (56 bpm) were measured. He had no fever, his body height was 180 cm, and his body weight 62 kg (BMI 19.1).

Laboratory examination revealed an elevated white blood cell count (15.40 × 10^3^/μL), as well as elevated serum lipase (191 U/L), bilirubin (1.48 mg/dL), and blood glucose (353 mg/dL) levels. The international normalized ratio was 1.2.

Sonographically, the previously described pancreatic pseudocyst revealed a slightly increased maximum diameter of 65 mm and an inhomogeneous echo of the cystic content (Fig. [1a](#F1){ref-type="fig"}, b). Color-coded Doppler sonography showed a turbulent blood flow in parts of the cyst (Fig. [1c](#F1){ref-type="fig"}).

The patient was transferred to our tertiary care center for further evaluation and therapy. A contrast-enhanced CT scan at admission (Fig. [2](#F2){ref-type="fig"}) showed multiple calcifications in the head and body of the pancreas, as well as an irregularly widened pancreatic duct as signs of a chronic pancreatitis. There were no signs of an acute pancreatitis. The known pseudocyst showed a further increase in maximum diameter to 70 mm (arrows). Inside the pseudocyst, a pseudoaneurysm originating from the splenic artery with a maximum diameter of 41 mm was visualized (asterisk), classified as type IIA2 \[[@B13]\]. After interdisciplinary consultation, prophylactic coil embolization of the splenic artery was immediately performed to prevent spontaneous bleeding. The splenic artery was accessed via a right transfemoral approach (Fig. [3a](#F3){ref-type="fig"}--c). The pseudoaneurysm was shut off from blood supply by back-door/front-door occlusion employing 27 coils, resulting in complete exclusion of the pseudoaneurysm from the circulation (Fig. [3d](#F3){ref-type="fig"}).

Six weeks after coil embolization, a control CT scan showed a stable condition of the pseudocyst without any signs of reperfusion of the pseudoaneurysm or of infection. There were no signs of infarction of the spleen, with good arterial circulation arising from strong collaterals.

Discussion {#sec1_3}
==========

In this case report, we described the very rare situation of an arterial pseudoaneurysm within a pancreatic pseudocyst in a patient suffering from chronic pancreatitis and report on its successful, prophylactic therapy to prevent critical bleeding.

Pancreatic pseudocysts often do not need any therapy, as up to 60% of them resolve spontaneously \[[@B14]\]. In case of complications such as abdominal pain, jaundice, splenic vein thrombosis, infection, or impression of the stomach with early satiety, weight loss, and nausea/vomiting, drainage might be indicated \[[@B1], [@B15]\]. According to a recent review, endoscopic ultrasound-guided drainage is the optimal drainage approach in uncomplicated pseudocysts that are located adjacent to the stomach or duodenum. However, radiologic or surgical drainage might be indicated in complicated cases.

Regarding intestinal pseudoaneurysms, the optimal therapeutic strategy, including arterial embolization and surgical procedures, is still controversial \[[@B9], [@B10]\]. Nevertheless, based on the widespread availability and minimal invasiveness, contrast-enhanced CT and digital subtraction angiography have been widely used to detect visceral arterial bleeding sites. Furthermore, due to the improved technical capabilities of interventional radiology, angioembolization should be considered as the first-line therapy to stop the bleeding in patients with bleeding pseudoaneurysms \[[@B9], [@B10]\]. Due to the infrequency of arterial pseudoaneurysms, data on diagnostics and prophylactic therapy to prevent bleeding are rare. Arterial pseudoaneurysms in pancreatitis are associated with nonspecific symptoms, requiring a high degree of suspicion for an early diagnosis \[[@B16]\]. An individualized diagnostic approach combining sound anamnesis, thorough clinical examination, and technical approaches such as endoscopic ultrasound, CT, or MRI are mandatory. According to the sparse literature on this topic, endovascular intervention is highly effective and should be the preferred treatment option \[[@B17], [@B18]\].
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![**a**, **b** Transabdominal ultrasound showing a pancreatic pseudocyst with a maximum diameter of 65 mm and an inhomogeneous echo of the cystic content. **c** Color-coded Doppler sonography showed a turbulent blood flow in parts of the cyst.](crg-0012-0513-g01){#F1}

![Contrast-enhanced CT scan showing a pancreatic pseudocyst with a maximum diameter of 70 mm (arrows). Inside the pseudocyst is a pseudoaneurysm originating from the splenic artery with a maximum diameter of 41 mm (asterisk).](crg-0012-0513-g02){#F2}

![**a--c** Digital subtraction angiography with a right transfemoral access showing the splenic artery and a pseudoaneurysm. **d** The pseudoaneurysm was shut off from blood supply by back-door/front-door occlusion employing 27 coils, resulting in complete exclusion of the pseudoaneurysm from the circulation.](crg-0012-0513-g03){#F3}
